Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS: 4 vs 6 Cycles of Cisplatin Chemo in Urothelial Carcinoma
NCT03296306Phase 3Unknown
- Sponsor
- Asan Medical Center
- Start
- Sep 2016
- Primary completion
- Aug 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in urothelial carcinoma (UC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03296306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296306.